What Is Pace of Aging and Why It's More Useful Than a Single Biological Age Number

A biological age score tells you where you landed. Pace of aging tells you whether you're moving in the right direction. Here's why that distinction matters for anyone tracking longevity.

Written by the Nuvo Longevity editorial team at Firefly Labs LLC.

Pace of Aging

Most people who track biological age get one number, once a year, from a blood panel or an epigenetic clock test. That number tells you where you landed. It says nothing about whether you're moving in the right direction right now, this week, based on what you did yesterday.

That distinction matters more than most longevity tools acknowledge.

Biological Age vs Pace of Aging: Two Different Questions

A biological age score answers one question: how old does my body appear to be, biologically, right now?

Pace of aging answers a different one: how fast am I aging?

They're related, but not the same. Someone with a biological age of 38 at a chronological age of 45 has a favorable snapshot. But if their pace of aging is accelerated, that gap will close. The snapshot looked good. The trajectory didn't.

This is the core idea behind DunedinPACE, a pace-of-aging measure developed from the Dunedin Study — a longitudinal cohort tracked from birth in Dunedin, New Zealand. Research by Belsky and colleagues, published in eLife in 2022, showed that DunedinPACE could be calculated from DNA methylation patterns in a single blood sample. Instead of estimating biological age as a fixed number, it produces a rate: how many biological years you're accumulating per calendar year. A score of 1.0 means aging at the expected pace. A score of 1.2 means aging 20 percent faster than average. A score of 0.8 means aging slower.

The measure has since been validated across more than 65 cohorts in 17 or more countries, making it one of the most replicated pace-of-aging signals in the literature.

Why a Single Biological Age Number Has Real Limits

The appeal of a biological age score is obvious. One number, easy to interpret, easy to act on. The problem is how rarely you get it.

A standard epigenetic clock test or comprehensive blood panel happens once or twice a year, if that. You see a number, go home, and make decisions for the next six months with no feedback on whether those decisions are working.

That lag isn't a minor inconvenience. It's a structural problem.

Say your CRP is elevated at your annual blood draw. That result reflects inflammation that built up over months. By the time you see the number, the window to course-correct has already passed. You adjust your habits, wait another six months, and hope the next panel looks better. The feedback loop is measured in quarters, not days.

This is the core limitation of static biological age measurement: it's a photograph, not a film. You see where you were. You don't see whether you're improving.

Biological Age vs Pace of Aging in Practice

The distinction becomes clearest when you apply it to something real.

Say you add consistent zone 2 cardio and regular sauna sessions over a six-week stretch. You want to know if it's working. A static biological age test can't tell you — your next blood panel is months away, and an epigenetic clock test costs several hundred dollars and takes weeks to return results.

But a continuous signal, one that tracks multiple biomarkers day over day, can show you trend direction within weeks. Not a final verdict. A directional signal.

If your resting heart rate is dropping, your sleep consistency is improving, and your recovery scores are trending upward across that six-week window, you're seeing early physiological evidence that the intervention is having an effect. If those signals are flat or worsening, you have useful information before the next lab draw — not after.

This is what pace-of-aging research points toward as the practical goal: not just knowing your biological age at a point in time, but having enough continuous signal to see whether your rate of aging is shifting in response to what you're actually doing.

Rate of Aging, Wearables, and the Daily Signal Problem

Wearables have made continuous physiological monitoring accessible in ways that weren't possible five years ago. Apple Watch captures resting heart rate, VO2 Max, sleep duration, sleep consistency, heart rate zones, and more — every day, without a lab visit.

The challenge is that raw wearable data and blood biomarker data have historically lived in separate places. Your Apple Watch tells you about cardiovascular and sleep patterns. Your blood panel tells you about metabolic and inflammatory markers. Neither alone gives you a complete picture of your rate of aging.

The rate of aging wearable problem isn't a hardware problem. It's an integration problem.

When wearable signals and blood biomarkers are fused into a single daily score, the result starts to approximate what pace-of-aging research is trying to measure: a continuous, multi-system signal that reflects how your biology is responding to your choices in something close to real time.

How Nuvo Approaches This

Nuvo Longevity is not an epigenetic clock and doesn't claim to be DunedinPACE. Those are specific research-grade tools that require DNA methylation analysis from a lab sample.

What Nuvo does is different — and practically complementary. It fuses 21 biomarkers connected from two sources: wearable data synced daily from Apple Watch via HealthKit (including VO2 Max, resting heart rate, sleep duration, sleep consistency, zone 2–3 and zone 4–5 heart rate time, lean mass percentage, and strength time) and blood test results you enter manually from any lab panel you already have (including CRP, HbA1c, fasting glucose, HDL cholesterol, ApoB, creatinine, and others).

From those 21 biomarkers connected, the app calculates a daily biological age score. Not quarterly. Not annually. Daily.

That daily recalculation is where the pace-of-aging concept becomes actionable without a lab. If your recovery scores, resting heart rate trend, and sleep consistency are all moving in a favorable direction over four to six weeks, your daily biological age score reflects that movement. You're not waiting for the next blood draw to find out whether your habits are working.

The app also logs specific recovery interventions — sauna, cold plunge, breathwork, meditation, red light therapy, and massage — so you can see what moves your score in response to specific choices, not just in response to time passing.

Nuvo Intelligence, the app's on-device, encrypted AI coach, generates personalized nutrition and supplement protocols tied to out-of-range biomarkers. All processing happens on your device. No account is required. No data is transmitted externally.

Pricing is $2.08 per month billed annually, or $4.99 per month billed monthly — a different category entirely from epigenetic clock tests or comprehensive lab panels, which typically run hundreds of dollars per draw.

The intended use is as a continuous layer between periodic lab tests. You still get your blood panels. You still run an epigenetic clock test if you want one. Nuvo fills the gap between those snapshots with a daily trend signal that tells you whether you're moving in the right direction.

What the Research Suggests About Frequency

DunedinPACE and related pace-of-aging research consistently show that biological aging is not a fixed rate. It responds to behavior. Sleep deprivation accelerates methylation-based aging signals. Exercise and metabolic health slow them. In some studies, these effects appear within weeks, not years.

That has a direct practical implication: if your pace of aging responds to behavior on short timescales, a tool that only reports once a year is missing most of the signal. The feedback loop needs to be shorter than the behavior change cycle to be useful.

Daily or weekly tracking doesn't replace periodic lab testing. It makes periodic lab testing more interpretable — by giving you context for what happened between draws.

Frequently Asked Questions

What is pace of aging?
Pace of aging measures how fast someone is biologically aging at a given point in time, expressed as a rate rather than a static age estimate. A pace of 1.0 means aging at the expected rate. Above 1.0 means aging faster than average. DunedinPACE, developed from the Dunedin longitudinal study and validated in 65-plus cohorts across 17-plus countries, is the most well-validated pace-of-aging measure currently available. It's derived from DNA methylation patterns in a blood sample.

Is pace of aging more accurate than biological age?
They measure different things, so "more accurate" isn't quite the right frame. A biological age score tells you where your biology appears to be at a single point in time. Pace of aging tells you the rate at which you're moving. Both are useful. Pace of aging is arguably more actionable because it reflects whether your current habits are accelerating or slowing your aging trajectory — rather than just reporting a snapshot.

How often should I test biological age?
A formal epigenetic clock or comprehensive blood panel once or twice a year is reasonable for most people. The limitation is the gap between tests. A daily score that fuses wearable and blood data — like the one Nuvo calculates — gives you directional trend data between those periodic tests, so you're not making decisions blind for six months at a time.

Can wearable data tell me my pace of aging?
Wearable data alone can't replicate an epigenetic clock. But signals like resting heart rate, VO2 Max, sleep consistency, and heart rate zone distribution are validated correlates of biological aging rate. When fused with blood biomarkers, they produce a continuous signal that approximates pace-of-aging direction without requiring repeat lab draws.

What biomarkers are most relevant to pace of aging?
Research consistently highlights inflammatory markers like CRP, metabolic markers like HbA1c and fasting glucose, and cardiovascular fitness markers like VO2 Max and resting heart rate — alongside sleep quality. These are among the biomarkers Nuvo tracks across wearable and blood data sources.

Does Nuvo replace an epigenetic clock test?
No. Nuvo is a complementary tool, not a replacement for DNA methylation-based testing or clinical lab work. It fills the gap between periodic tests with a daily trend signal so you can see whether your habits are moving your biology in the right direction between formal assessments.

Why does daily recalculation matter?
Biological aging responds to behavior on short timescales. If your pace of aging can shift in response to sleep, exercise, and metabolic health within weeks, then a tool that only reports once a year is missing most of the signal. Daily recalculation gives you a feedback loop that's actually short enough to be useful.

A single biological age number is a useful reference point. But it's a photograph of where you were — not a signal of where you're going. Pace-of-aging research makes clear that the rate matters as much as the number, and that the rate responds to what you do day to day.

The practical gap — between expensive annual tests and the daily decisions that shape your trajectory — is exactly what continuous tracking is built to fill. Learn more at nuvolongevity.com.